• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

0.125%阿托品治疗儿童近视疗效的早期识别:一项前瞻性初步研究。

Early identification of the efficacy of 0.125% atropine treatment for children with Myopia: A prospective pilot study.

作者信息

Chen Zi-Rong, Wan Tsung-Yao, Chuang Lan-Hsin, Lai Chi-Chun, Hwang Yih-Shiou, Kuo Yu-Kai, Chen Ho-Min, Chang Po-Chun, Chen Hung-Chi, Liu Chun-Fu

机构信息

Department of Family Medicine, Cheng Ching Hospital, Taichung, Taiwan.

College of Medicine, Chang Gung University, Taoyuan, Taiwan.

出版信息

PLoS One. 2025 Aug 7;20(8):e0327354. doi: 10.1371/journal.pone.0327354. eCollection 2025.

DOI:10.1371/journal.pone.0327354
PMID:40773486
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12331118/
Abstract

PURPOSE

This study aimed to investigate whether early axial length (AL) changes in the short term after 0.125% atropine treatment could predict long-term axial elongation in children with myopia.

METHODS

This was a prospective cohort study involving children aged 5-15 years with myopia who were treated with 0.125% atropine for myopia control. AL was measured 1-2 months after starting treatment and then every 3 months for follow-up visits. Regression analysis was used to develop a model of AL changes with time. A generalized estimating equation (GEE) model was then used to identify correlations between the early AL changes and long-term AL changes.

RESULTS

Eighty eyes of 40 patients (mean age 8.4 years) were included in the final analysis. The estimation curve of AL changes with time indicated that the AL decreased at 67 days (the turning point in the regression model) after 0.125% atropine treatment and then increased gradually with time. Univariate GEE showed that a larger AL elongation in the initial 4 months was significantly associated with AL changes at 6 months (β = 0.354, P = 0.020, 6 ~ 12 months period from baseline) and 12 months (β = 0.560, P = 0.045, 6 ~ 18 months period from baseline) after that period in all myopic eyes.

CONCLUSIONS

The magnitude of AL elongation in the initial 4 months of 0.125% atropine treatment correlated positively with the further half-year and one-year AL changes. Identifying these changes may be useful for controlling refractory myopia in children.

摘要

目的

本研究旨在探讨0.125%阿托品治疗后短期内早期眼轴长度(AL)变化是否可预测近视儿童的长期眼轴伸长。

方法

这是一项前瞻性队列研究,纳入了5-15岁近视儿童,他们接受0.125%阿托品治疗以控制近视。在开始治疗后1-2个月测量眼轴长度,随后每3个月进行一次随访测量。采用回归分析建立眼轴长度随时间变化的模型。然后使用广义估计方程(GEE)模型确定早期眼轴长度变化与长期眼轴长度变化之间的相关性。

结果

最终分析纳入了40例患者(平均年龄8.4岁)的80只眼。眼轴长度随时间变化的估计曲线表明,0.125%阿托品治疗后67天(回归模型中的转折点)眼轴长度下降,随后随时间逐渐增加。单变量GEE分析显示,在最初4个月内眼轴伸长幅度较大与此后所有近视眼中6个月(β = 0.354,P = 0.020,从基线起6至12个月)和12个月(β = 0.560,P = 0.045,从基线起6至18个月)的眼轴长度变化显著相关。

结论

0.125%阿托品治疗最初4个月内眼轴伸长幅度与接下来半年和一年的眼轴长度变化呈正相关。识别这些变化可能有助于控制儿童难治性近视。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0965/12331118/63b287b22243/pone.0327354.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0965/12331118/b06010195b14/pone.0327354.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0965/12331118/63b287b22243/pone.0327354.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0965/12331118/b06010195b14/pone.0327354.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0965/12331118/63b287b22243/pone.0327354.g002.jpg

相似文献

1
Early identification of the efficacy of 0.125% atropine treatment for children with Myopia: A prospective pilot study.0.125%阿托品治疗儿童近视疗效的早期识别:一项前瞻性初步研究。
PLoS One. 2025 Aug 7;20(8):e0327354. doi: 10.1371/journal.pone.0327354. eCollection 2025.
2
Interventions for myopia control in children: a living systematic review and network meta-analysis.儿童近视控制干预措施:一项实时系统评价和网状Meta分析
Cochrane Database Syst Rev. 2025 Feb 13;2(2):CD014758. doi: 10.1002/14651858.CD014758.pub3.
3
Interventions for myopia control in children: a living systematic review and network meta-analysis.儿童近视防控干预措施的系统评价和网络荟萃分析。
Cochrane Database Syst Rev. 2023 Feb 16;2(2):CD014758. doi: 10.1002/14651858.CD014758.pub2.
4
Atropine (0.05%) for rapid progressive childhood myopia (ARM study).用于快速进展性儿童近视的阿托品(0.05%)(近视进展研究)
Indian J Ophthalmol. 2025 Mar 1;73(3):358-361. doi: 10.4103/IJO.IJO_1526_24. Epub 2024 Dec 27.
5
Orthokeratology, 0.04% Atropine, and 0.01% Atropine for Myopia Control: A Randomized Clinical Trial.角膜塑形术、0.04%阿托品和0.01%阿托品控制近视:一项随机临床试验。
JAMA Ophthalmol. 2025 Jul 24. doi: 10.1001/jamaophthalmol.2025.2321.
6
The effect of 0.01% atropine and orthokeratology on ocular axial elongation for myopia children: A meta-analysis (a PRISMA-compliant article).0.01%阿托品和角膜塑形术对近视儿童眼轴伸长影响的Meta 分析(一篇符合 PRISMA 标准的文章)。
Medicine (Baltimore). 2022 May 6;101(18):e29191. doi: 10.1097/MD.0000000000029191.
7
Five-year results of atropine 0.01% efficacy in the myopia control in a European population.在欧洲人群中,0.01%阿托品对近视控制的 5 年疗效。
Br J Ophthalmol. 2024 May 21;108(5):715-719. doi: 10.1136/bjo-2022-322808.
8
Baseline factors associated with myopia progression and axial elongation over 30 months in children 5 to 12 years of age.5 至 12 岁儿童 30 个月内近视进展和眼轴伸长相关的基线因素。
Optom Vis Sci. 2024 Oct 1;101(10):619-626. doi: 10.1097/OPX.0000000000002187.
9
Effectiveness of a split-dose, twice-daily low-dose atropine monocular treatment in children with anisometropia: a retrospective study.分剂量、每日两次低剂量阿托品单眼治疗儿童屈光参差的有效性:一项回顾性研究。
Int Ophthalmol. 2025 Jun 23;45(1):257. doi: 10.1007/s10792-025-03625-z.
10
Topical Atropine for Childhood Myopia Control: The Atropine Treatment Long-Term Assessment Study.阿托品治疗儿童近视控制的长期评估研究。
JAMA Ophthalmol. 2024 Jan 1;142(1):15-23. doi: 10.1001/jamaophthalmol.2023.5467.

本文引用的文献

1
Evaluating the effect of 0.125% atropine on foveal microvasculature using optical coherence tomography angiography.使用光学相干断层扫描血管造影术评估0.125%阿托品对黄斑中心凹微血管系统的影响。
Sci Rep. 2025 Feb 18;15(1):5970. doi: 10.1038/s41598-025-88025-0.
2
Relationship between axial length and spherical equivalent refraction in Chinese children.中国儿童眼轴长度与等效球镜度之间的关系。
Adv Ophthalmol Pract Res. 2021 Nov 13;1(2):100010. doi: 10.1016/j.aopr.2021.100010. eCollection 2021 Dec.
3
Treatment of Myopia with Atropine 0.125% Once Every Night Compared with Atropine 0.125% Every Other Night: A Pilot Study.
每晚一次使用0.125%阿托品与隔晚一次使用0.125%阿托品治疗近视的初步研究。
J Clin Med. 2023 Aug 10;12(16):5220. doi: 10.3390/jcm12165220.
4
A comparison of myopia control in European children and adolescents with defocus incorporated multiple segments (DIMS) spectacles, atropine, and combined DIMS/atropine.多焦点离焦眼镜(DIMS)、阿托品与 DIMS/阿托品联合治疗欧洲儿童青少年近视控制的比较。
PLoS One. 2023 Feb 16;18(2):e0281816. doi: 10.1371/journal.pone.0281816. eCollection 2023.
5
Synergistic effects of defocus-incorporated multiple segments and atropine in slowing the progression of myopia.离焦多区联合阿托品减缓近视进展的协同作用。
Sci Rep. 2022 Dec 24;12(1):22311. doi: 10.1038/s41598-022-25599-z.
6
Axial Elongation During Short-Term Accommodation in Myopic and Nonmyopic Children.近视和非近视儿童短期调节时的轴向伸长。
Invest Ophthalmol Vis Sci. 2022 Mar 2;63(3):12. doi: 10.1167/iovs.63.3.12.
7
Evaluation of axial length to identify the effects of monocular 0.125% atropine treatment for pediatric anisometropia.评估眼轴长度以确定 0.125%阿托品单眼治疗儿童屈光参差的效果。
Sci Rep. 2021 Nov 2;11(1):21511. doi: 10.1038/s41598-021-96414-4.
8
Prevalence and risk factors for myopia in Taiwanese diabetes mellitus patients: a multicenter case-control study in Taiwan.台湾地区糖尿病患者近视患病率及危险因素:台湾多中心病例对照研究。
Sci Rep. 2021 Apr 14;11(1):8195. doi: 10.1038/s41598-021-87499-y.
9
One-year myopia control efficacy of spectacle lenses with aspherical lenslets.具有非球面微透镜的眼镜镜片一年近视控制效果。
Br J Ophthalmol. 2022 Aug;106(8):1171-1176. doi: 10.1136/bjophthalmol-2020-318367. Epub 2021 Apr 2.
10
CLEAR - Orthokeratology.科视角塑形角膜接触镜(Clear - Orthokeratology)。
Cont Lens Anterior Eye. 2021 Apr;44(2):240-269. doi: 10.1016/j.clae.2021.02.003. Epub 2021 Mar 25.